Reclassification of gabapentin and pregabalin as CDs from 1st April 2019 – update

Reclassification of gabapentin and pregabalin as CDs from 1st April 2019 – update

March 14, 2019

Community pharmacy teams are reminded that from 1st April 2019, pregabalin and gabapentin will be reclassified as Schedule 3 Controlled Drugs (CDs).NHS England has published a guidance document providing information on changes to the law relating to the reclassification of the drugs gabapentin and pregabalin and a patient leaflet informing patients of the changes and how it will affect them.Pharmacy teams are also reminded of the national roll-out of Schedule 2 and 3 CDs in EPS. This means that the number of CD prescriptions that pharmacies receive via EPS will increase significantly as more GP practices have the functionality switched on.

PSNC’s updated briefing provides detailed information for community pharmacy teams with answers to some commonly raised questions.

NHE England Controlled Drugs regulations and resources



Posted in:


More Latest News >

Concessions webinar on-demand

Community pharmacy contractors can now access an online recording of our recent price concessions webinar. The webinar described how concessionary...

Interim guidance on FMD alerts

Whilst in the initial phase of Falsified Medicines Directive (FMD) implementation, many “false positive” alerts are expected. This does not...

NHS England FMD Advice Notice

Please see below an advice notice from NHS England on implementation of the FMD requirements and these proceeding with appropriate...